Cita APA (7a ed.)

Xie, X., Lv, J., Zhu, W., Tian, C., Li, J., Liu, J., . . . Li, X. (2022). The combination therapy of oncolytic HSV-1 armed with anti-PD-1 antibody and IL-12 enhances anti-tumor efficacy. Elsevier.

Cita Chicago Style (17a ed.)

Xie, Xin, et al. The Combination Therapy of Oncolytic HSV-1 Armed with Anti-PD-1 Antibody and IL-12 Enhances Anti-tumor Efficacy. Elsevier, 2022.

Cita MLA (8a ed.)

Xie, Xin, et al. The Combination Therapy of Oncolytic HSV-1 Armed with Anti-PD-1 Antibody and IL-12 Enhances Anti-tumor Efficacy. Elsevier, 2022.